XML 104 R93.htm IDEA: XBRL DOCUMENT v3.22.2
ACQUISTITIONS AND INVESTMENTS - MANA Corporation (Details)
3 Months Ended 5 Months Ended 12 Months Ended
Feb. 28, 2022
USD ($)
Jul. 24, 2021
shares
Jul. 23, 2021
USD ($)
installment
shares
lb
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
Business Acquisition [Line Items]                  
Revenue of acquiree since acquisition date       $ 0          
Impairment of goodwill and intangible assets       (350,000)     $ (6,394,610) $ 0  
Change in fair value of derivative instruments       3,065,000 $ 7,487,249   (13,155,946) 427,838  
Goodwill, Impairment Loss       $ 0     6,163,846    
Impairment of notes receivable, prepaid assets and other deposits             (1,076,258) $ 0  
Escrow deposit           $ 500,000 500,000    
LP Biosciences LLC                  
Business Acquisition [Line Items]                  
Payment in cash             1,076,258    
Leasehold security interest     $ 4,600,000            
LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary                  
Business Acquisition [Line Items]                  
Ownership percentage     50.00%            
Daily production of industrial hemp (pounds) | lb     200,000            
Secured promissory note, principal amount     $ 17,000,000            
Secured promissory note     15,000,000            
Legal expense incurred     $ 1,500,000            
Interest rate     13.50%            
Potential increase in promissory note     $ 3,000,000            
Preferred distribution     $ 5,000,000            
Potential Increase in promissory note (percent)     20.00%            
Escrow deposit           $ 500,000 $ 500,000   $ 500,000
LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary | Subsequent Event                  
Business Acquisition [Line Items]                  
Legal expense incurred $ 250,000                
LP Biosciences LLC | Common Class A                  
Business Acquisition [Line Items]                  
Convertible, number of shares purchased | shares     500,000            
Restricted Stock | LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary                  
Business Acquisition [Line Items]                  
Fair value of equity issued in acquisition     $ 10,800,000            
MANA Corporation                  
Business Acquisition [Line Items]                  
Percentage of voting interests acquired     100.00% 100.00%   100.00% 100.00%    
Purchase consideration in decreased             $ 6,163,846    
Revenue of acquiree since acquisition date       $ 0   $ 100,000      
Income (loss) of acquiree since acquisition date       252,000   (13,442,547)      
Impairment of goodwill and intangible assets           (6,394,610)      
Goodwill, Impairment Loss             $ 230,764    
MANA Corporation | LP Biosciences LLC                  
Business Acquisition [Line Items]                  
Change in fair value of derivative instruments       $ 595,000   $ (6,300,000)      
MANA Corporation | Restricted Stock                  
Business Acquisition [Line Items]                  
Issuance of common stock (in shares) | shares   4,200,000 4,200,000            
Comstock shares of common stock issued     $ 6,528,453            
MANA Corporation | Restricted Stock | Vesting period one                  
Business Acquisition [Line Items]                  
Lockup provision for restricted shares percent     28.00%            
MANA Corporation | Restricted Stock | Vesting period two                  
Business Acquisition [Line Items]                  
Lockup provision for restricted shares percent     72.00%            
Lockup provision, shares released in each installment     9.00%            
Number of equal installments | installment     8            
LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary                  
Business Acquisition [Line Items]                  
Percentage of voting interests acquired     50.00%            
LP Biosciences LLC | Restricted Stock | Variable Interest Entity, Not Primary Beneficiary                  
Business Acquisition [Line Items]                  
Shares issued in connection with investment and financing commitments (shares) | shares     3,500,000            
Loss on contract termination 250,000                
LP Biosciences LLC | Restricted Stock | Variable Interest Entity, Not Primary Beneficiary | Subsequent Event                  
Business Acquisition [Line Items]                  
Loss on contract termination $ 750,000